Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.67 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.67 |
| ▸ | EPAS1 | Q99814 | 11/20 | 0.38 |
| ▸ | THRA | P10827 | 2/20 | 0.36 |
| ▸ | THRB | P10828 | 2/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.36 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5373619 | 0.92 | CYP3A4 (0.58) | CYP3A4CYP2C9CYP2C19EPAS1THRA | |
| SCHEMBL5364923 | 0.89 | CYP3A4 (0.60) | CYP3A4CYP2C9CYP2C19EPAS1THRA | |
| SCHEMBL14559741 | 0.89 | CYP3A4 (0.75) | CYP3A4CYP2C9CYP2C19EPAS1THRA | |
| SCHEMBL5365033 | 0.89 | CYP3A4 (0.54) | CYP3A4CYP2C9CYP2C19EPAS1THRA | |
| SCHEMBL5366810 | 0.84 | CYP3A4 (0.49) | CYP3A4CYP2C9CYP2C19THRATHRB | |
| SCHEMBL5368884 | 0.83 | CYP3A4 (0.68) | CYP3A4CYP2C9CYP2C19THRATHRB | |
| SCHEMBL5668069 | 0.83 | CYP3A4 (0.76) | CYP3A4CYP2C9CYP2C19EPAS1KCNH2 | |
| SCHEMBL5373271 | 0.83 | CYP3A4 (0.68) | CYP3A4CYP2C9CYP2C19EPAS1THRA | |
| SCHEMBL5377615 | 0.82 | CYP3A4 (0.60) | CYP3A4CYP2C9CYP2C19EPAS1THRA | |
| SCHEMBL5377332 | 0.82 | CYP3A4 (0.49) | CYP3A4CYP2C9CYP2C19EPAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7189718-B2 | Non-nucleoside reverse transcriptase inhibitors | ROCHE PALO ALTO LLC (US) | 2007-03-13 | — | — | US | disclosed |
| US-7189718-B2 | Non-nucleoside reverse transcriptase inhibitors | ROCHE PALO ALTO LLC (US) | 2007-03-13 | — | — | US | disclosed |
| US-7189718-B2 | Non-nucleoside reverse transcriptase inhibitors | ROCHE PALO ALTO LLC (US) | 2007-03-13 | — | — | US | disclosed |